Surveys of substance use disorders education in US pharmacy programs

Abstract Introduction: Substance use disorders (SUDs) are a significant US health problem affecting roughly 20 million Americans, but there continues to be limited access to SUD treatment and inadequate addiction medicine training. Therefore, it is important to understand how SUD education is being delivered to US health professionals, including pharmacists. Methods: A recent survey of US pharmacy programs' neuropsychiatry curricula was evaluated to identify any progress made toward increasing SUD education since the last national survey in 2004 and determine any remaining gaps between what is currently being taught and American Association of Colleges of Pharmacy (AACP) curricular guidelines for SUD education updated in 2010. A survey of psychiatric pharmacists, regarding what they thought should be taught, was also evaluated and compared with the 2010 AACP curricular guidelines. Results: Our survey of US pharmacy programs demonstrated that 94% of programs reported teaching SUD content in 2014-15, which has increased from 81% reported in a survey study from 2004. There was also an increase for average hours of SUD didactic instruction, which increased from 2.2 hours in 2004 to 2.7 hours in 2015. The majority of members (84%) recommended at least 2 hours of SUD instruction, and 27% recommended teaching ≥4 hours. Discussion: There was an overall increase in SUD instruction, but the average hours taught still falls short of 2010 AACP curricular guideline recommendation suggesting ≥4 hours. Furthermore, a majority of the psychiatric pharmacists we surveyed did not agree with the AACP curricular guideline recommendation because only 27% of members recommended ≥4 hours of SUD instruction, and the average hours recommended was only 2.7 hours.

Download Full-text

Substance use Treatment and Harm Reduction Services for Migrants and Refugees in the COVID-19 Pandemic: Findings from a Global Survey

10.21203/rs.3.rs-123740/v1 ◽

2020 ◽

Author(s):

Cornelis De Jong ◽

Ali Farhoudian ◽

Mehrnoosh Vahidi ◽

Mohsen Ebrahimi ◽

Hamed Ekhtiari ◽

...

Keyword(s):

Substance Use ◽

Harm Reduction ◽

Substance Use Disorders ◽

Mental Health Problems ◽

World Health ◽

Substance Use Treatment ◽

Second Phase ◽

Addiction Medicine ◽

Global Survey ◽

The Impact

Abstract Migrants and refugees are considered vulnerable to mental health problems and substance use disorders; and may be particularly affected by service disruptions associated with the COVID-19 pandemic The International Society of Addiction Medicine (ISAM) ran a multi-phased global survey among clinicians and health professional that are actively working in the field of addiction medicine to investigate the impact of the COVID-19 pandemic on substance use and related services. In March 2020, the first month after the announcement of the pandemic by the World Health Organization, 177 informants from 77 countries took part in the global survey, and only 12.9% of them reported their countries’ substance use treatment and harm reduction services for the migrants and refugees with substance use disorders continued as usual. In May 2020, 11.7% of respondents of the second phase reported that the services for refugees and migrants improved in comparison to March 2020; 11.7% reported that these services in their country discontinued. Results suggest that refugee and migrants access to treatment and harm reduction services has been reduced as a result of COVID-19. It can be concluded that it is crucial to improve the visibility of migrants’ needs and exploit appropriate interventions for those with substance use disorders.

Download Full-text

Substance use disorders and self- and other-directed violence among adults: Results from the National Survey on Drug Use And Health

Journal of Affective Disorders ◽

10.1016/j.jad.2017.08.021 ◽

2018 ◽

Vol 225 ◽

pp. 365-373 ◽

Cited By ~ 12

Author(s):

Thomas C. Harford ◽

Hsiao-ye Yi ◽

Chiung M. Chen ◽

Bridget F. Grant

Keyword(s):

Substance Use ◽

Drug Use ◽

Substance Use Disorders ◽

National Survey ◽

Self And Other

Download Full-text

Closing the gap between training needs and training provision in addiction medicine

BJPsych International ◽

10.1192/bji.2019.27 ◽

2019 ◽

Vol 17 (2) ◽

pp. 37-39

Author(s):

Sidharth Arya ◽

Mirjana Delic ◽

Blanca Iciar Indave Ruiz ◽

Jan Klimas ◽

Duccio Papanti ◽

...

Keyword(s):

Substance Use ◽

Substance Use Disorders ◽

Training Needs ◽

Addiction Medicine ◽

Effective Interventions ◽

Sufficient Detail ◽

Core Set ◽

Wide Range ◽

Closing The Gap ◽

And Training

Substance use disorders pose a significant global social and economic burden. Although effective interventions exist, treatment coverage remains limited. The lack of an adequately trained workforce is one of the prominent reasons. Recent initiatives have been taken worldwide to improve training, but further efforts are required to build curricula that are internationally applicable. We believe that the training needs of professionals in the area have not yet been explored in sufficient detail. We propose that a peer-led survey to assess those needs, using a standardised structured tool, would help to overcome this deficiency. The findings from such a survey could be used to develop a core set of competencies which is sufficiently flexible in its implementation to address the specific needs of the wide range of professionals working in addiction medicine worldwide.

Download Full-text

Attention-deficit/hyperactivity disorder (ADHD) in adults: Specific clinical and therapeutic issues

European Psychiatry ◽

10.1016/j.eurpsy.2015.09.083 ◽

2015 ◽

Vol 30 (S2) ◽

pp. S27-S28

Author(s):

B. Rolland ◽

D. Da Fonseca ◽

M. Fatseas ◽

N. Simon

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Substance Use ◽

Substance Use Disorders ◽

Clinical Features ◽

Attention Deficit ◽

Adult Adhd ◽

Adhd Symptoms ◽

Addiction Medicine ◽

Global Functioning ◽

Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) was initially considered as a childhood psychiatric disorder. However, longitudinal observations have revealed that ADHD symptoms may persist in adulthood among approximately 50% of the patients . Adult ADHD is associated with impaired social outcome and frequent comorbidities such as mood disorders, personality disorders, and substance use disorders [2,3]. Correctly identifying and treating ADHD can significantly improve the global functioning and cognition of adult subjects, and reduce the intensity and frequency of the comorbid states [2,3]. Nonetheless, the clinical features of adult ADHD are clearly different from the youth form [1,2], and ADHD symptoms are easily mixed up in adults with symptoms of the comorbid conditions [2,3]. These clinical intricacies can make the diagnosis of ADHD difficult in adults. Moreover, the management of methylphenidate in adult subjects is also associated with specific risks and pitfalls, such as abuse and tampering behaviors, and additional safety risks . Put together, it appears crucial to identify and treat ADHD in adults, but the clinical and therapeutic complexities of adult ADHD require improved expertise and caution from adult psychiatrists and addiction specialists. In this thematic session of the 2015 French Psychiatry Congress, three French leading experts of adult ADHD will address the aforementioned clinical and therapeutic issues of the adulthood form of this disorder. David Da Fonseca, professor of child psychiatry in Marseille, will disentangle the clinical features of adult ADHD from the typical symptoms observed in the youth form. Mélina FATSEAS, associate professor of psychiatry and addiction medicine in Bordeaux, will specifically focus on the many and complex relationships observed between adult ADHD and substance use disorders. Last, Nicolas Simon, professor of addiction medicine and psychopharmacology in Marseille, will synthesize what are the very risks and issues with prescribing methylphenidate in adults.

Download Full-text

Promoting Early Intervention for Substance Use Disorders Through Interdisciplinary Education for Health Professionals

Journal of Addictions Nursing ◽

10.1080/10884600500231946 ◽

2005 ◽

Vol 16 (3) ◽

pp. 153-160 ◽

Cited By ~ 7

Author(s):

Katherine Fornili ◽

Mary R. Haack

Keyword(s):

Substance Use ◽

Early Intervention ◽

Substance Use Disorders ◽

Health Professionals ◽

Interdisciplinary Education

Download Full-text

Insurance Receipt and Readiness for Opportunities under the Affordable Care Act: A National Survey of Treatment Providers for Substance Use Disorders

Journal of Psychoactive Drugs ◽

10.1080/02791072.2017.1306661 ◽

2017 ◽

Vol 49 (2) ◽

pp. 141-150 ◽

Cited By ~ 3

Author(s):

Lydia Aletraris ◽

Mary Bond Edmond ◽

Paul M. Roman

Keyword(s):

Substance Use ◽

Substance Use Disorders ◽

National Survey ◽

Affordable Care Act ◽

Treatment Providers ◽

The Affordable Care Act

Download Full-text

A national survey of training in substance use disorders in residency programs.

Journal of Studies on Alcohol ◽

10.15288/jsa.2000.61.912 ◽

2000 ◽

Vol 61 (6) ◽

pp. 912-915 ◽

Cited By ~ 78

Author(s):

J H Isaacson ◽

M Fleming ◽

M Kraus ◽

R Kahn ◽

M Mundt

Keyword(s):

Substance Use ◽

Substance Use Disorders ◽

National Survey ◽

Residency Programs

Download Full-text

Physicians who use substances: what does it look like and what to do about it?

Neurology Bulletin ◽

10.17816/nb19060 ◽

2020 ◽

Vol LII (1) ◽

pp. 9-13

Author(s):

Yury P. Sivolap ◽

Vladimir A. Savchenkov ◽

Maksim V. Yanushkevich ◽

Pavel V. Pushin

Keyword(s):

Substance Use ◽

Substance Use Disorders ◽

Medical Specialty ◽

Medical Community ◽

Physical And Mental Health ◽

Therapeutic Approaches ◽

Addiction Medicine ◽

Quality Of Patient Care ◽

Community And Public Health

Substance use disorders in physicians is a serious problem of the medical community and public health. The prevalence of substance use disorders depends on gender, age and medical specialty. The substance abuse impairs physical and mental health of physicians and affects the quality of patient care. Treatment of chemically addicted physicians involves the use of conventional therapeutic approaches adopted in addiction medicine, but requires compliance with certain special principles.

Download Full-text

Providing Integrated Care for Pain and Addiction (DRAFT)

10.1093/med/9780190265366.003.0005 ◽

2018 ◽

Author(s):

Alan A. Wartenberg

Keyword(s):

Substance Use ◽

Integrated Care ◽

Substance Use Disorders ◽

Multidisciplinary Approach ◽

Current Standard ◽

Addiction Medicine ◽

Additional Information ◽

Pain Syndromes ◽

Assessment And Treatment ◽

The Common

The central premise of this chapter on providing integrated care for both pain and addiction is that all patients presenting with pain are at risk for development of substance use disorders. Assessment and treatment of the complex interplay between pain syndromes and substance use disorders proceed most productively by employing an integrated model, with a multidisciplinary approach and with employment of multiple diagnostic instruments. The author describes an integrated care model as it applies to each of the common substances of use: opioids, tobacco, alcohol, benzodiazepines, cannabinoids, barbiturates, and stimulants. The basis for a decision to refer for evaluation or treatment is described. The chapter concludes with an argument for collaboration between disciplines, notably pain medicine and addiction medicine, as being the current standard of acceptable care for patients whose illnesses dwell in both camps. A separate text box provides additional information and resources bearing on this chapter’s topics.

Download Full-text